ABVCABVC BioPharma, Inc.
Nov 14, 2026 — Q3 2026 Earnings Release
Chart by TradingViewThe schedule
- Sat14Nov
- Sun14Feb
- Sat15May
- Wed11Aug
Past
- Wed12Aug
Actual outcome: Bear · $0.93 at outcome
ABVC reported Q2 2026 earnings with EPS of $0.13, exactly meeting analyst estimates. Despite the in-line bottom line, the stock closed at $0.96, well below the bear floor of $1.23. The negative price action indicates that investors were disappointed by the broader financial details or a lack of compelling forward guidance to support a higher valuation.